Keybanc analyst Justin Patterson initiates coverage on Redfin (NASDAQ:RDFN) with a Sector Weight rating.
HC Wainwright Slashes PT On This Stock By 50%? Here Are 5 Other Price Target Changes For Tuesday
HC Wainwright & Co. cut the price target on Mind Medicine (MindMed) Inc. (NASDAQ: MNMD) from $10 to $5. HC Wainwright & Co. analyst Patrick Trucchio maintained the stock with a Buy rating. Mind Medicine shares rose 2.3% to $0.7164 in pre-market trading.